For following the competition: what moved in each program, several studies read as one move.
- zanzalintinib
- WRN Inhibitor NDI-219216
Mondays · ranked, phase 3 first · readouts ahead · See a sample brief
Add Microsatellite Instability to watchlistEvery Monday by email · turn it off any timePro · free during the beta